Navigation Links
Structure-Based Drug Design Conference in Boston, Starting June 19 PLUS These 62 Start-ups and Small Companies Will Transform Drug Delivery Technology

FARMINGTON, Conn., June 5, 2013 /PRNewswire-iReach/ -- From Global Information and MCD Group, a new report "Early Stage Drug Delivery Technologies" profiles 62 start-ups and small companies that have interest in forming new partnerships or receiving funding to enable further development and eventual commercialization of their drug delivery technologies. All of the companies investigated are developing technologies that could potentially transform drug delivery in one or more therapeutic areas.


Lauren Sciences LLC is one of the 62 start-ups and small companies that are expected to gain momentum as they advance their drug delivery technologies and produce significant clinical data. At Lauren Sciences, their proprietary V-Smart V-SmartTM nanovesicle technology has already demonstrated the ability to cross the blood-brain barrier (BBB) and deliver encapsulated contents directly to the brain.

Benefits of reading this report:

  • Identify early stage delivery technologies that will potentially "enable" the delivery of your therapeutic compound;
  • Learn about investment opportunities to gain access to promising early stage technologies;
  • Identify novel drug delivery formulations available for partnering to enhance your firm's product portfolio.

The following list provides a sampling of the start-ups and small companies profiled in this report by therapeutic category.

Emerging companies developing breakthrough treatments for cancer: Blend Therapeutics, Centrose, Intensity Therapeutics

Emerging companies developing proprietary devices for subcutaneous drug delivery: scPharmaceuticals, Ratio, Inc.

Emerging companies focused on ophthalmic drug delivery technologies:Clearside Biomedical, Corinthian Opthalmic, iVeena

Emerging companies focused on effective delivery technology for large molecular weight drugs such as antibody-based therapeutics, proteins, and peptides: Entrega, Extend, Biosciences, Solstice Biologics

Gain access to all of the 62 emerging company profiles by ordering the report online from our website:

Structure-Based Drug Design

Genome to Drug Lead with Big Data Approach

June 19 – 21, 2013 | Boston, MA | The Revere Hotel

Structure-Based Drug Design 2013 is coming up in two weeks. This year's conference will feature developments in insilico technology, experimental approaches for accurately predicting and modeling protein structures in structure-based drug design, and examples of successful applications of approaches to genome-to-drug lead investigations.

>> Learn more at

Register online at  We hope to see you June 19 in Boston!

Event Organizers: Need to reach biodefense and biomedical technology executives in Asia?
GlobalReach currently provides event marketing services for over 300 events annually in Japanese, Korean, and both Simplified and Traditional Chinese, reaching thousands of sponsors and attendees. A portfolio of their work and pricing information can be found at

About GlobalReach Offering affordable fixed-price translation, localization, and conference marketing services, GlobalReach bridges the gap between cultures to connect organizers with the fastest growing markets on the planet. For over a decade, Global Information Inc, through our GlobalReach event service, has connected conference and event organizers in the West with attendees, exhibitors, and sponsors in the East.

About Global Information Inc. Global Information (GII) ( is an information service company partnering with over 400 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 30 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Joe Malley Global Information, Inc., 1-860-674-8796,  

News distributed by PR Newswire iReach:

SOURCE Global Information, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. TeraDiscoveries to Use its Inverse Design Software Running on Windows Azure to Advance Its Computational Drug Discovery Process
2. Telik Announces the Publication of Two Reports in the Journal Of Hematology & Oncology Describing the Results of a Clinical Study of Telintra® in Combination With Revlimid® and a Genomic Study Designed to Identify Genes That Predict Response to Teli
3. UBM Canon and MD+DI Proudly Announce 25 Innovative Products as Winners of the 2012 Medical Design Excellence Awards
4. Breathe Technologies Non-Invasive Open Ventilation (NIOV™) System Receives Medical Design Award
5. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
6. Anthony Creed Joins DDSTUDIO As GM, Experience Design
7. CSL Behring Receives FDA Orphan Drug Designation for rIX-FP, a Novel Therapy in Development to Treat Congenital Factor IX Deficiency (Hemophilia B)
8. UBM Canon, the Global MedTech Authority, and the Medical Design Excellence Awards Honored Dr. Thomas Fogarty with the 2012 Lifetime Achievement Award
9. Derry Medical and Derry Imaging Select Calypso for Website Redesign
10. Spot Vision Screener wins Bronze in International Design Excellence Awards
11. WaferGen Bio-systems Launches MyDesign - Setting a New Standard in Flexibility with an Open Format High-Throughput qPCR Platform
Post Your Comments:
(Date:9/27/2017)... their devotion to personalized service, SMP Pharmacy Solutions announces their ... South Florida Business Journal,s 50 Fastest-Growing Companies, and listed for ... specialty pharmacy has found its niche.  To that end, the ... by SFBJ as the 2017 Power Leader in Health Care. ... award in October, Bardisa said of the three achievements, "It,s ...
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
(Date:9/19/2017)... --  ZirMed Inc ., a recognized leader in cloud-based revenue ... been ranked #1 by its users for the seventh consecutive ... Survey. ZirMed was recognized as the top-ranked end-to-end revenue cycle ... over 200 beds and holds one of the longest #1 ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian ... On The Brink” is the creation of published author, William Nowers. Captain Nowers ... a WWII veteran, he spent thirty years in the Navy. Following his career ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... to meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s ... experts and tested to meet the highest standard. , These products are ...
(Date:10/12/2017)... Bethesda, MD (PRWEB) , ... October 12, 2017 , ... ... Award of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s ... 4 – 8. , In honor of Morris F. Collen, a pioneer in the ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... system that we intend to develop to enable prevention of a major side ... severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA ...
Breaking Medicine News(10 mins):